Skip to content
Finasteride Info

Finasteride Info

Emerging evidence & commentary on risks of finasteride as a treatment for hair loss

  • Home
  • Drug information
    • Overview
    • Drug labels
    • How finasteride was invented
    • Historical timeline
  • Weighing risks
    • Lasting dysfunctions
    • Firsthand reports
    • Weighing the risks of taking finasteride
    • Adverse event data
    • Doctors expressing concerns
  • Research
    • Research overview
    • 2020–present
    • Earlier research
      • 2015–2019
      • 2010–2014
      • 2000–2009
      • 1942–1999
    • By system & function
    • – Lasting dysfunctions
    • – Effects on fertility
    • Special topics
    • Clinical trials
    • Related research
    • Grey literature
    • All bibliographies
    • History of research
  • Resources
    • Resources – main
    • Physicians expressing concerns
    • Historical timeline
    • News & media coverage
    • Regulatory activity
    • Legal matters
    • The Merck files
    • Posts archive
    • About this site
    • Search

ANSM France

Regulators are waking from their slumber

April 5, 2023April 4, 2023 by Montaigne

Agencies in France, the United Kingdom, Canada and the United States are strengthening warnings about finasteride risks

Categories News, Regulation & FDA Tags ANSM France, Drug label, FDA, Health Canada, Regulation, UK MHRA

Many websites tout the benefits of finasteride for treating hair loss, while downplaying the risks. This site is different: it puts risks in the foreground, accompanied by supporting evidence. Learn more

  • Considering taking finasteride or dutasteride for hair loss? See Weighing the risks

Navigator

  • Adverse event data
  • Drug information
  • Drug origins
  • Firsthand reports
  • Media coverage
  • Post-drug disorder
  • Regulation
  • Research
  • Search site
  • Site index
  • Timeline
  • Weighing the risks

Categories

  • Adverse event reports (18)
  • Doctor views (9)
  • Firsthand experiences (18)
  • History & context (11)
  • Merck (16)
  • News (7)
  • Regulation & FDA (7)
  • Research (21)
Tweets by FinasterideInfo
  • Home
  • Drug information
  • Research
  • Posts archive
  • Site index
  • Search
  • About & contact
  • Medical Disclaimer

Recent Posts

  • The lost men: how Merck, GSK papered over bad outcomes in trials
  • The lost men – appendix
  • From LSD to Zoloft, drugs can leave lasting damage
  • Men’s fitness influencers are raising alarms about finasteride risks
  • Firsthand reports – Volume XIII: User reviews

Post categories

  • Adverse event reports (18)
  • Doctor views (9)
  • Firsthand experiences (18)
  • History & context (11)
  • Merck (16)
  • News (7)
  • Regulation & FDA (7)
  • Research (21)

© 2020–2023 Finasteride Info  •  Privacy Policy
This website is not a substitute for professional medical advice, diagnosis or treatment. See Medical Disclaimer